Kim, Min Hwan
Kim, Jae-Hwan
Lee, Ji Min
Choi, Jae Woo
Jung, Dongmin
Cho, Hojin
Kang, Hyundeok
Hong, Min Hee
Heo, Su Jin
Kim, Se Heon
Choi, Eun Chang
Kim, Da Hee
Park, Young Min
Kim, Sangwoo
Yoon, Sun Och
Koh, Yoon Woo
Cho, Byoung Chul
Kim, Hye Ryun
Funding for this research was provided by:
Daewoong Pharmaceutical Company (DF-201906-0000001)
Yonsei University | Yonsei University College of Medicine (No. 6-2017-0104)
National Research Foundation of Korea (2017M3A9E802971, 2017M3A9E9072669)
Ministry of Health and Welfare (HA16C0015020019)
Article History
Received: 9 September 2019
Revised: 11 February 2020
Accepted: 24 February 2020
First Online: 1 April 2020
Change Date: 22 June 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-020-0944-1
Ethics approval and consent to participate
: This study was reviewed and approved by the Institutional Review Board of Severance Hospital. Informed consent was obtained from all participants. This study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
: The authors declare no competing interests.
: This research was supported by the Young Medical Scientist Research Grant through the Deawoong Foundation (DY18111P), by the Bio & Medical Technology Development Programme of the National Research Foundation (NRF) funded by the Ministry of Science and ICT (2017M3A9E8029717, 2017M3A9E9072669, 2019M3A9B6065231) and by a grant from the National R&D Programme for Cancer Control, Ministry of Health and Welfare (HA16C0015). This study was also supported by the Research Foundation of Yonsei University (No. 6-2017-0104).